MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scapagnini, G.
Right arrow Articles by Motterlini, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scapagnini, G.
Right arrow Articles by Motterlini, R.

Vol. 61, Issue 3, 554-561, March 2002

Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers

G. Scapagnini,1 R. Foresti, V. Calabrese, A. M. Giuffrida Stella, C. J. Green, and R. Motterlini

Department of Biochemistry (G.S., V.C., A.M.G.S.) and Department of Experimental and Clinical Pharmacology (G.S.), Faculty of Medicine, University of Catania, Catania, Italy; and Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research, Harrow, Middlesex, United Kingdom (R.F., C.J.G., R.M.)

Heme oxygenase-1 (HO-1) is a redox-sensitive inducible protein that provides efficient cytoprotection against oxidative stress. Curcumin, a polyphenolic natural compound that possesses anti-tumor and anti-inflammatory properties, has been reported recently to induce potently HO-1 expression in vascular endothelial cells (Free Rad Biol Med 28:1303-1312, 2000). Here, we extend our previous findings by showing that caffeic acid phenethyl ester (CAPE), another plant-derived phenolic agent, markedly increases heme oxygenase activity and HO-1 protein in astrocytes. The effect seems to be related to the peculiar chemical structures of curcumin and CAPE, because analogous antioxidants containing only portions of these two molecules were totally ineffective. At a final concentration of 30 µM, both curcumin and CAPE maximally up-regulated heme oxygenase activity while promoting marked cytotoxicity at higher concentrations (50-100 µM). Similar results were obtained with Curcumin-95, a mixture of curcuminoids commonly used as a dietary supplement. Incubation of astrocytes with curcumin or CAPE at concentrations that promoted maximal heme oxygenase activity resulted in an early increase in reduced glutathione followed by a significant elevation in oxidized glutathione contents. A curcumin-mediated increase in heme oxygenase activity was not affected by the glutathione precursor and thiol donor N-acetyl-L-cysteine. These data suggest that regulation of HO-1 expression by polyphenolic compounds is evoked by a distinctive mechanism which is not necessarily linked to changes in glutathione but might depend on redox signals sustained by specific and targeted sulfydryl groups. This study identifies a novel class of natural substances that could be used for therapeutic purposes as potent inducers of HO-1 in the protection of tissues against inflammatory and neurodegenerative conditions.


1 Current address: Blanchette Rockefeller Neurosciences Institute, Rockville, MD 20850.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Acquaviva, R. Lanteri, G. Li Destri, R. Caltabiano, L. Vanella, S. Lanzafame, A. Di Cataldo, G. Li Volti, and C. Di Giacomo
Beneficial effects of rutin and L-arginine coadministration in a rat model of liver ischemia-reperfusion injury
Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G664 - G670.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. I. Schwer, A. M. Guerrero, M. Humar, M. Roesslein, U. Goebel, P. Stoll, K. K. Geiger, B. H. J. Pannen, A. Hoetzel, and R. Schmidt
Heme Oxygenase-1 Inhibits the Proliferation of Pancreatic Stellate Cells by Repression of the Extracellular Signal-Regulated Kinase1/2 Pathway
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Javvadi, A. T. Segan, S. W. Tuttle, and C. Koumenis
The Chemopreventive Agent Curcumin Is a Potent Radiosensitizer of Human Cervical Tumor Cells via Increased Reactive Oxygen Species Production and Overactivation of the Mitogen-Activated Protein Kinase Pathway
Mol. Pharmacol., May 1, 2008; 73(5): 1491 - 1501.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Alam and J. L. Cook
How Many Transcription Factors Does It Take to Turn On the Heme Oxygenase-1 Gene?
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-S. Keum, S. Yu, P. P.-J. Chang, X. Yuan, J.-H. Kim, C. Xu, J. Han, A. Agarwal, and A.-N. T. Kong
Mechanism of Action of Sulforaphane: Inhibition of p38 Mitogen-Activated Protein Kinase Isoforms Contributing to the Induction of Antioxidant Response Element-Mediated Heme Oxygenase-1 in Human Hepatoma HepG2 Cells.
Cancer Res., September 1, 2006; 66(17): 8804 - 8813.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Erdmann, N. Grosser, K. Schipporeit, and H. Schroder
The ACE Inhibitory Dipeptide Met-Tyr Diminishes Free Radical Formation in Human Endothelial Cells via Induction of Heme Oxygenase-1 and Ferritin
J. Nutr., August 1, 2006; 136(8): 2148 - 2152.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. W. Ryter, J. Alam, and A. M. K. Choi
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Physiol Rev, April 1, 2006; 86(2): 583 - 650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Abuarqoub, R. Foresti, C. J. Green, and R. Motterlini
Heme oxygenase-1 mediates the anti-inflammatory actions of 2'-hydroxychalcone in RAW 264.7 murine macrophages
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1092 - C1099.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. K. Andreadi, L. M. Howells, P. A. Atherfold, and M. M. Manson
Involvement of Nrf2, p38, B-Raf, and Nuclear Factor-{kappa}B, but Not Phosphatidylinositol 3-Kinase, in Induction of Hemeoxygenase-1 by Dietary Polyphenols
Mol. Pharmacol., March 1, 2006; 69(3): 1033 - 1040.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. D. Maines
New Insights into Biliverdin Reductase Functions: Linking Heme Metabolism to Cell Signaling
Physiology, December 1, 2005; 20(6): 382 - 389.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Wu and R. Wang
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. M. Ogborne, S. A. Rushworth, and M. A. O'Connell
{alpha}-Lipoic Acid-Induced Heme Oxygenase-1 Expression Is Mediated by Nuclear Factor Erythroid 2-Related Factor 2 and p38 Mitogen-Activated Protein Kinase in Human Monocytic Cells
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2100 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Wijayanti, T. Kietzmann, and S. Immenschuh
Heme Oxygenase-1 Gene Activation by the NAD(P)H Oxidase Inhibitor 4-(2-Aminoethyl) Benzenesulfonyl Fluoride via a Protein Kinase B, p38-dependent Signaling Pathway in Monocytes
J. Biol. Chem., June 10, 2005; 280(23): 21820 - 21829.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Foresti, M. Hoque, D. Monti, C. J. Green, and R. Motterlini
Differential Activation of Heme Oxygenase-1 by Chalcones and Rosolic Acid in Endothelial Cells
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 686 - 693.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
H. F. Poon, V. Calabrese, G. Scapagnini, and D. A. Butterfield
Free Radicals: Key to Brain Aging and Heme Oxygenase as a Cellular Response to Oxidative Stress
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): M478 - M493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Martin, A. I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C. M. R. de Galarreta, and A. Cuadrado
Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol
J. Biol. Chem., March 5, 2004; 279(10): 8919 - 8929.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Colombrita, V. Calabrese, A. M. G. Stella, F. Mattei, D. L. Alkon, and G. Scapagnini
Regional Rat Brain Distribution of Heme Oxygenase-1 and Manganese Superoxide Dismutase mRNA: Relevance of Redox Homeostasis in the Aging Processes
Experimental Biology and Medicine, May 1, 2003; 228(5): 517 - 524.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics